Pharmacogenetics in HIV therapy: a review of key biomarkers, regulatory annotations, and clinical dosing guidelines

Rita Nogueiras-Álvarez

Open source

DOI
10.1080/14622416.2026.2746614
Published
2026-10-16
Container
Pharmacogenomics
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14622416.2026.2746614,
  title = {Pharmacogenetics in HIV therapy: a review of key biomarkers, regulatory annotations, and clinical dosing guidelines},
  author = {Rita Nogueiras-Álvarez},
  year = {2026},
  journal = {Pharmacogenomics},
  doi = {10.1080/14622416.2026.2746614},
  url = {https://doi.org/10.1080/14622416.2026.2746614}
}

RIS

TY  - JOUR
TI  - Pharmacogenetics in HIV therapy: a review of key biomarkers, regulatory annotations, and clinical dosing guidelines
AU  - Rita Nogueiras-Álvarez
PY  - 2026
JO  - Pharmacogenomics
DO  - 10.1080/14622416.2026.2746614
UR  - https://doi.org/10.1080/14622416.2026.2746614
ER  - 

APA

Nogueiras-Álvarez, R. (2026). Pharmacogenetics in HIV therapy: a review of key biomarkers, regulatory annotations, and clinical dosing guidelines. Pharmacogenomics. https://doi.org/10.1080/14622416.2026.2746614

Source records